Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for angiotensin root_names_stdName in Standardized Name (approximate match)

Showing 1231 - 1240 of 1776 results

First page
Previous page
Next page
Next page

Silicified Microcrystalline Cellulose (65 µm)

K2EZE348C4

Status:

Excipient

Source:

Source URL:

https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S

Class:

G1 SPECIFIED SUBSTANCE

OPADRY II Y-30-18037 WHITE

RX96DK7VVX

Status:

Excipient

Source:

26mg ORAL TABLET, FILM COATED, EXTENDED RELEASE

Source URL:

https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O

Class:

G1 SPECIFIED SUBSTANCE

OPADRY II RED 85G94101

A2E86PPP6D

Status:

Excipient

Source:

Source URL:

https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O

Class:

G1 SPECIFIED SUBSTANCE

OPADRY II Y-22-7719 WHITE

B38S8YKT74

Status:

Excipient

Source:

Source URL:

https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O

Class:

G1 SPECIFIED SUBSTANCE

OPADRY II 85F18422 WHITE

UM45RMS9QT

Status:

Excipient

Source:

Source URL:

https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O

Class:

G1 SPECIFIED SUBSTANCE

OPADRY II 85F18378 WHITE

VTB5DCJ7N6

Status:

Excipient

Source:

Source URL:

https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O

Class:

G1 SPECIFIED SUBSTANCE

OPADRY II 33G11938 GREEN

B53ZH89YAO

Status:

Excipient

Source:

Source URL:

https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O

Class:

G1 SPECIFIED SUBSTANCE

OPADRY II 32K580000 WHITE

OQ25C9K54Z

Status:

Possibly Marketed Outside US

Source:

ANDA078329

(2024)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b19b8c34-e0c1-4982-92fc-34dbe7384935

First approved in 2024

Source:

ANDA078329

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b19b8c34-e0c1-4982-92fc-34dbe7384935

Class:

G1 SPECIFIED SUBSTANCE

Silicified Microcrystalline Cellulose (125 µm)

88X4A2YW6T

Status:

Possibly Marketed Outside US

Source:

ANDA211729

(2021)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=136bbd47-7a54-493f-9158-a84d39221d6c

First approved in 2021

Source:

ANDA211729

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=136bbd47-7a54-493f-9158-a84d39221d6c

Class:

G1 SPECIFIED SUBSTANCE

ISOTONIC SODIUM CHLORIDE SOLUTION

VR5Y7PDT5W

Status:

Possibly Marketed Outside US

Source:

NCT04404127: Phase 4 Interventional Recruiting Kidney Transplantation

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04404127

First approved in 2020

Source:

505G(a)(3)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fad70060-8bb6-4b06-a353-666132f64c26

Class:

G1 SPECIFIED SUBSTANCE

Concept

Silicified Microcrystalline Cellulose (65 µm)

RX96DK7VVX
Not a public record

Concept

OPADRY II Y-30-18037 WHITE

A2E86PPP6D
Not a public record

Concept

OPADRY II RED 85G94101

B38S8YKT74
Not a public record

Concept

OPADRY II Y-22-7719 WHITE

UM45RMS9QT
Not a public record

Concept

OPADRY II 85F18422 WHITE

VTB5DCJ7N6
Not a public record

Concept

OPADRY II 85F18378 WHITE

Concept

OPADRY II 33G11938 GREEN

OQ25C9K54Z
Not a public record

Concept

OPADRY II 32K580000 WHITE

Concept

Silicified Microcrystalline Cellulose (125 µm)

Concept

ISOTONIC SODIUM CHLORIDE SOLUTION

Showing 1231 - 1240 of 1776 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1